TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21756794

Group type: EXPERIMENTAL
Intervention: Implantation of compound artificial bone of HA-Bone cement
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no implantation)
Number of subjects: 40
Study: 19131469

Group type: EXPERIMENTAL
Intervention: Interactive weekly automated telephone self-management support with nurse follow-up (ATSM)
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Monthly group medical visits with physician and health educator facilitation (GMV)
Number of subjects: 339

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 339
Study: 16359822

Group type: EXPERIMENTAL
Intervention: Estradiol challenge test (estradiolbenzoate 0.04 mg/kg, intramuscular injection)
Number of subjects: 25
Study: 15650497

Group type: EXPERIMENTAL
Intervention: Fluoxetine (10 mg-60 mg daily for up to 19 weeks)
Number of subjects: 96
Study: 11269568

Group type: EXPERIMENTAL
Intervention: A/L/Z combination tablet after an overnight fast
Number of subjects: 24

Group type: COMPARATOR
Intervention: Abacavir 300 mg + Lamivudine 150 mg + Zidovudine 300 mg tablets after an overnight fast
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: A/L/Z combination tablet 5 minutes after a standardized high-fat breakfast
Number of subjects: 24
Study: 9204091

Group type: EXPERIMENTAL
Intervention: Adapalene gel 0.1%
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Adapalene gel
Number of subjects: 680
Study: 8135618

Group type: EXPERIMENTAL
Intervention: Consent to participate in a trial
Number of subjects: 541

Group type: COMPARATOR
Intervention: Refusal to participate in a trial
Number of subjects: 541

Group type: EXPERIMENTAL
Intervention: Agreement between parents
Number of subjects: 541

Group type: COMPARATOR
Intervention: Reasons for refusal
Number of subjects: 541

Group type: EXPERIMENTAL
Intervention: Age of mothers who consented
Number of subjects: 541

Group type: EXPERIMENTAL
Intervention: Education level of consent group
Number of subjects: 541
Study: 2883988

Group type: EXPERIMENTAL
Intervention: H-I 42 BS 50 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: H-I 42 BS 100 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: H-I 42 BS 200 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: H-I 42 BS 400 mg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Atenolol 50 mg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Atenolol 100 mg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: H-I 42 BS 400 mg vs Atenolol 50 mg
Number of subjects: 17
Study: 31283891

Group type: EXPERIMENTAL
Intervention: Topical CHQ 0.03% twice a day with carboxymethylcellulose (CMC) 0.5% three times a day
Number of subjects: 150

Group type: COMPARATOR
Intervention: Topical CMC 0.5% three times a day
Number of subjects: 150
Study: 28864027

Group type: EXPERIMENTAL
Intervention: Tribendimidine 400 mg plus ivermectin 200 μg/kg
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Tribendimidine 400 mg plus oxantel pamoate 25 mg/kg
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Tribendimidine 400 mg plus placebo (monotherapy)
Number of subjects: 636

Group type: COMPARATOR
Intervention: Albendazole 400 mg plus oxantel pamoate 25 mg/kg
Number of subjects: 636
Study: 27755601

Group type: EXPERIMENTAL
Intervention: Primary prevention using misoprostol (600 mcg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Secondary prevention using misoprostol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost analysis of primary prevention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cost analysis of secondary prevention
Number of subjects: 0
Study: 24530023

Group type: EXPERIMENTAL
Intervention: Intraoperative intracameral injection of 1.2 mg/0.03 mL of triamcinolone acetonide
Number of subjects: 60

Group type: COMPARATOR
Intervention: Postoperative oral prednisolone (1 mg/kg per day for 15 days, tapered over 2 weeks)
Number of subjects: 60
Study: 22866670

Group type: EXPERIMENTAL
Intervention: autologous PRP injection with rehabilitation programme
Number of subjects: 28

Group type: COMPARATOR
Intervention: rehabilitation programme only
Number of subjects: 28
Study: 20804229

Group type: EXPERIMENTAL
Intervention: Internal fixation devices
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total hip replacements
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mortality
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pain, functioning, and QoL
Number of subjects: 0
Study: 17893257

Group type: EXPERIMENTAL
Intervention: Exercise training (aerobic exercise 45 min/session, 300 Kcal/day and muscle strength training 20 min/session, 100 Kcal/day, five times per week for 12 weeks)
Number of subjects: 48
Study: 15047594

Group type: EXPERIMENTAL
Intervention: Smelling strawberry
Number of subjects: 0

Group type: COMPARATOR
Intervention: Smelling ham
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imagined odors
Number of subjects: 0
Study: 12431940

Group type: EXPERIMENTAL
Intervention: Flunkimmune (hypothetical drug)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 11228858

Group type: EXPERIMENTAL
Intervention: Dual-chamber pacemaker implantation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 20
Study: 7582390

Group type: EXPERIMENTAL
Intervention: MPC-1304
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 0
Study: 2924158

Group type: EXPERIMENTAL
Intervention: Hypnotic anesthesia
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 518108

Group type: EXPERIMENTAL
Intervention: 1 mg folic acid daily supplement from age 2 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31442204

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT) in addition to conventional pharmacological treatment with Indacaterol-Glycopyrronium
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional pharmacological treatment with Indacaterol-Glycopyrronium
Number of subjects: 32
Study: 28919126

Group type: EXPERIMENTAL
Intervention: Low-dose CT (2 mSv)
Number of subjects: 3074

Group type: COMPARATOR
Intervention: Standard-dose CT (≤8 mSv)
Number of subjects: 3074
Study: 26343746

Group type: EXPERIMENTAL
Intervention: Parent mentors trained in positively deviant behaviors regarding childhood obesity
Number of subjects: 60

Group type: COMPARATOR
Intervention: Community health workers delivering health education on obesity‐related behaviors
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Parent mentors
Number of subjects: 60
Study: 24995688

Group type: EXPERIMENTAL
Intervention: Botulinum Toxin A (BoNT‐A)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 22383296

Group type: EXPERIMENTAL
Intervention: Encapsulated fruit and vegetable juice powder concentrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19295227

Group type: EXPERIMENTAL
Intervention: Art therapy intervention
Number of subjects: 18

Group type: COMPARATOR
Intervention: Comparison group (n = 48)
Number of subjects: 18
Study: 18063846

Group type: COMPARATOR
Intervention: Off-pump CABG (group B)
Number of subjects: 22

Group type: COMPARATOR
Intervention: On-pump CABG (group A)
Number of subjects: 22
Study: 15235718

Group type: EXPERIMENTAL
Intervention: MMSE-mo (modified Mini-Mental State Examination)
Number of subjects: 232

Group type: COMPARATOR
Intervention: MMSE-ad (adapted Mini-Mental State Examination)
Number of subjects: 232
Study: 11173147

Group type: EXPERIMENTAL
Intervention: Pretreatment kinetic parameter LI (labeling index)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pretreatment Tpot measurements using flow cytometry
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immunohistochemistry measuring LI
Number of subjects: 0
Study: 9745996

Group type: EXPERIMENTAL
Intervention: Polyamide hemofiltration
Number of subjects: 0
Study: 8042760

Group type: EXPERIMENTAL
Intervention: Continuous infusion of tramadol (100 mg loading dose, 12 mg/h for 24 h)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Continuous infusion of tramadol
Number of subjects: 135

Group type: COMPARATOR
Intervention: Repetitive bolus administration (placebo infusion)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Repetitive bolus administration
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 135
Study: 2179363

Group type: EXPERIMENTAL
Intervention: Early mortality (0-3 months)
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Late mortality (3-12 months)
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Relative risk of early mortality compared to late mortality
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Risk factors for early mortality
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Risk factors for late mortality
Number of subjects: 515
Study: 600634

Group type: EXPERIMENTAL
Intervention: Motor recall (performing the movements)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Verbal recall (describing the movements)
Number of subjects: 16
Study: 31578627

Group type: EXPERIMENTAL
Intervention: Correlative Image Enhancement (CIE)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (normal children with no seizure history)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: CIE
Number of subjects: 27
Study: 31176137

Group type: EXPERIMENTAL
Intervention: Dissociation induction (n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (n = 25)
Number of subjects: 50
Study: 28918594

Group type: EXPERIMENTAL
Intervention: Pain at the knee (KP)
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: Pain at the knee and other sites (KOP)
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: Pain at other sites (OP)
Number of subjects: 891
Study: 26437320

Group type: EXPERIMENTAL
Intervention: CC ointment (CCO)
Number of subjects: 17

Group type: COMPARATOR
Intervention: hydrogel
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: CC or CC digests of collagen type I or III
Number of subjects: 17
Study: 23626984

Group type: EXPERIMENTAL
Intervention: Zirconia implants supporting maxillary four-implant overdentures and mandibular three-implant overdentures; 28 implants total (maxilla: 16, mandible: 12)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Zirconia implants
Number of subjects: 4
Study: 22256638

Group type: EXPERIMENTAL
Intervention: Anti-Ashi-points group (group A)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Ashi-points group (group B)
Number of subjects: 68
Study: 20048529

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 101

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 101
Study: 18557003

Group type: EXPERIMENTAL
Intervention: Disc 'O' Sit cushions used by 31 students in the treatment group for a 2-week period.
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group of 32 students not using the Disc 'O' Sit cushions.
Number of subjects: 63
Study: 15159224

Group type: EXPERIMENTAL
Intervention: Higher energy-dense entrée (7.32 kJ/g) served in the largest portion (900 g)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Lower energy-dense entrée (5.23 kJ/g) served in the smallest portion (500 g)
Number of subjects: 39
Study: 11454878

Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin (PLD) 50 mg/m² as a 1-hour infusion every 4 weeks
Number of subjects: 474

Group type: COMPARATOR
Intervention: Topotecan 1.5 mg/m²/d for 5 consecutive days every 3 weeks
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: PLD in platinum-sensitive patients
Number of subjects: 474

Group type: COMPARATOR
Intervention: Topotecan in platinum-sensitive patients
Number of subjects: 474

Group type: COMPARATOR
Intervention: Topotecan
Number of subjects: 474
Study: 9741512

Group type: EXPERIMENTAL
Intervention: Triple therapy (digoxin, diuretic, ACEI)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Digoxin and diuretic therapy
Number of subjects: 266

Group type: COMPARATOR
Intervention: ACEI and diuretic therapy
Number of subjects: 266

Group type: COMPARATOR
Intervention: Diuretic alone
Number of subjects: 266
Study: 7989963

Group type: EXPERIMENTAL
Intervention: Single-crystal aluminum ceramic (S)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Polycrystal aluminum ceramic (P)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control dentin specimen (D)
Number of subjects: 5
Study: 3055943

Group type: EXPERIMENTAL
Intervention: Cimetropium bromide (50 mg, tid)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 30495974

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4532
Study: 30341966

Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Vehicle (Control)
Number of subjects: 50
Study: 27418571

Group type: EXPERIMENTAL
Intervention: Heat-stressed dapagliflozin 2.5-mg tablets
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Heat-stressed dapagliflozin 10-mg tablets
Number of subjects: 57

Group type: COMPARATOR
Intervention: Heat-stressed dapagliflozin 2.5-mg tablets (fed state)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Heat-stressed dapagliflozin 10-mg tablets (fed state)
Number of subjects: 57
Study: 24566560

Group type: EXPERIMENTAL
Intervention: Evidence-based 12-week weight loss intervention (PREMIER with DASH diet)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 36
Study: 22808048

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ) alone
Number of subjects: 151

Group type: COMPARATOR
Intervention: Chloroquine (CQ) plus unobserved primaquine for either 5 days or 14 days
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Genotyping of P.vivax
Number of subjects: 151
Study: 20663239

Group type: EXPERIMENTAL
Intervention: Advancing Better Living for Elders (ABLE) intervention providing compensatory strategies
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Advancing Better Living for Elders (ABLE) intervention
Number of subjects: 148
Study: 17979895

Group type: EXPERIMENTAL
Intervention: ASM/body mass
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: ASM/height(2)
Number of subjects: 189
Study: 15309493

Group type: EXPERIMENTAL
Intervention: Contrast material with iodine concentration of 300 mg/ml
Number of subjects: 70

Group type: COMPARATOR
Intervention: Contrast material with iodine concentration of 370 mg/ml
Number of subjects: 70
Study: 12200512

Group type: EXPERIMENTAL
Intervention: LifeNet hotline services (part of Project Liberty) providing free education, outreach, and crisis counseling.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Project Liberty media campaign
Number of subjects: 0
Study: 10182115

Group type: EXPERIMENTAL
Intervention: Higher mean arterial pressure (MAP) during cardiopulmonary bypass (CPB); low-flow corrected CPB MAP of 77.7 +/- 7.1 mmHg
Number of subjects: 248

Group type: COMPARATOR
Intervention: Lower mean arterial pressure (MAP) during cardiopulmonary bypass (CPB); low-flow corrected CPB MAP of 56.7 +/- 5.0 mmHg
Number of subjects: 248
Study: 8092097

Group type: EXPERIMENTAL
Intervention: Beta-carotene (60 mg/d)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2690838

Group type: EXPERIMENTAL
Intervention: Nimodipine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard treatment with hydroxyethyl starch (HAES) and naftidrofuryl
Number of subjects: 80
Study: 30844881

Group type: EXPERIMENTAL
Intervention: Active tDCS stimulation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sham tDCS stimulation
Number of subjects: 34
Study: 27852935

Group type: EXPERIMENTAL
Intervention: RSLV-132
Number of subjects: 32
Study: 25450303

Group type: EXPERIMENTAL
Intervention: PCOM group
Number of subjects: 194

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 194
Study: 24419419

Group type: EXPERIMENTAL
Intervention: Pemetrexed
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Pemetrexed plus Sunitinib
Number of subjects: 125
Study: 22119182

Group type: EXPERIMENTAL
Intervention: Therapist-delivered brief intervention addressing alcohol misuse and violence
Number of subjects: 60
Study: 20087310

Group type: EXPERIMENTAL
Intervention: Creative dance program (12 weeks, 3 sessions of 90 minutes per week)
Number of subjects: 37
Study: 17291851

Group type: EXPERIMENTAL
Intervention: Prophylactic group (breast-fed with mother on a low allergen diet or given an extensively hydrolyzed formula)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Prophylactic group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (standard advice)
Number of subjects: 120
Study: 15475800

Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg per day for 60 days
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo for 60 days
Number of subjects: 38
Study: 11762668

Group type: EXPERIMENTAL
Intervention: Activated charcoal administered 1 hour after acetaminophen ingestion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Activated charcoal administered 2 hours after acetaminophen ingestion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Activated charcoal administered 3 hours after acetaminophen ingestion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no activated charcoal)
Number of subjects: 10
Study: 9248874

Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8501274

Group type: EXPERIMENTAL
Intervention: Amine/stannous fluoride rinse
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study: 2963166

Group type: EXPERIMENTAL
Intervention: hANP (Met12‐(3‐28)‐eicosahexapeptide, 2 micrograms/min)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Vehicle (Ve)
Number of subjects: 8
Study: 31738834

Group type: EXPERIMENTAL
Intervention: Sirolimus
Number of subjects: 127

Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Sirolimus (prednisone ≤0.25 mg/kg/day)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Prednisone (prednisone ≤0.25 mg/kg/day)
Number of subjects: 127
Study: 28438062

Group type: EXPERIMENTAL
Intervention: Financial incentives for smoking cessation during pregnancy
Number of subjects: 388

Group type: COMPARATOR
Intervention: Smoking during pregnancy
Number of subjects: 388
Study: 27159069

Group type: EXPERIMENTAL
Intervention: ACB with 10 mL lidocaine 1%
Number of subjects: 20
Study: 25700845

Group type: EXPERIMENTAL
Intervention: HMB with resistance training (RT-HMB)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No-training placebo (NT-PL)
Number of subjects: 48

Group type: COMPARATOR
Intervention: HMB only (NT-HMB)
Number of subjects: 48

Group type: COMPARATOR
Intervention: RT with placebo (RT-PL)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: HMB with RT (RT-HMB)
Number of subjects: 48
Study: 23866924

Group type: EXPERIMENTAL
Intervention: Berberine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 20602760

Group type: EXPERIMENTAL
Intervention: Ibuprofen (200 mg) and Paracetamol (500 mg) fixed-dose combination tablet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ibuprofen (200 mg) and Paracetamol (500 mg) fixed-dose combination tablet in fed state
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ibuprofen (200 mg) and Paracetamol (500 mg) fixed-dose combination tablet given three times daily
Number of subjects: 0
Study: 19034329

Group type: EXPERIMENTAL
Intervention: Atorvastatin (10-80 mg/day)
Number of subjects: 852
Study: 16473325

Group type: EXPERIMENTAL
Intervention: Cognitive restructuring imagery modification
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In vivo exposure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Minimal exposure, relaxation control
Number of subjects: 0
Study: 15143854

Group type: EXPERIMENTAL
Intervention: Mold exposure
Number of subjects: 209
Study: 10959067

Group type: EXPERIMENTAL
Intervention: Tramadol 50-400 mg/day
Number of subjects: 117
Study: 9497506

Group type: EXPERIMENTAL
Intervention: Gemfibrozil 1200 mg/day
Number of subjects: 27

Group type: COMPARATOR
Intervention: Lovastatin 40-80 mg at night
Number of subjects: 27
Study: 8396081

Group type: EXPERIMENTAL
Intervention: Azithromycin (10 mg/kg daily for 3 days)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Cloxacillin (dicloxacillin 12.5‐25 mg/kg daily for 7 days or flucloxacillin 250‐2000 mg/day for 7 days)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 118

Group type: COMPARATOR
Intervention: Cloxacillin (dicloxacillin or flucloxacillin)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Azithromycin and Cloxacillin (dicloxacillin or flucloxacillin)
Number of subjects: 118
Study: 3774197

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (various operations on the digestive tract)
Number of subjects: 140
Study: 29776444

Group type: EXPERIMENTAL
Intervention: Endosonography (EBUS and EUS) without mediastinoscopy
Number of subjects: 360

Group type: COMPARATOR
Intervention: Endosonography (EBUS and EUS) with mediastinoscopy
Number of subjects: 360
Study: 26894424

Group type: EXPERIMENTAL
Intervention: Hypnotic relaxation therapy (5 weekly sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 0
Study: 23830802

Group type: EXPERIMENTAL
Intervention: Small incision lenticule extraction (SMILE)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Femtosecond laser-assisted laser in situ keratomileusis (femto-LASIK)
Number of subjects: 30
Study: 21246186

Group type: EXPERIMENTAL
Intervention: Problem-solving counseling intervention (8 weekly sessions in groups of 8-10 adults)
Number of subjects: 420

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Problem-solving counseling intervention
Number of subjects: 420
Study: 20626160

Group type: EXPERIMENTAL
Intervention: Shang Ring circumcision
Number of subjects: 724

Group type: COMPARATOR
Intervention: Conventional surgical procedures
Number of subjects: 724
Study: 18543479

Group type: EXPERIMENTAL
Intervention: YQHX (supplementing qi and activating blood circulation method)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Conventional Western medicinal treatment
Number of subjects: 76
Study: 15968385

Group type: EXPERIMENTAL
Intervention: LPS inhalation
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline inhalation
Number of subjects: 6